Adenocarcinoma  >>  Novartis  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
patupilone (EPO 906) / Novartis           
          
            
             
Jakafi (ruxolitinib) / Incyte           
          
            
             
CRS-207 / Novartis           
          
            
             
GVAX Pancreas (allogeneic GM-CSF-secreting tumor cells) / Novartis           
          
            
             
dactolisib (RTB101) / Adicet Bio           
          
            
             
buparlisib (AN2025) / Novartis, Adlai Nortye           
          
            
             
GVAX lung cancer vaccine / Dana-Farber Cancer Institute, Novartis           
          
            
             
Tabrecta (capmatinib) / Incyte, Novartis           
          
            
             
Vynfinit (vintafolide) / Novartis           
          
            
             
bimagrumab (BYM338) / Novartis, MorphoSys, Eli Lilly           
          
            
             
figitumumab (CP-751,871) / Novartis